Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening
NCT ID: NCT05506631
Last Updated: 2025-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2021-11-01
2024-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
NCT01063244
Prehospital Cervical Ripening Before Induction and the Maternal Experience
NCT01641601
Outpatient Labor Induction With the Transcervical Foley Balloon
NCT02210598
Outpatient Foley For Starting Induction of Labor at TErm
NCT02756689
Patient Satisfaction of Cervical Ripening in an Outpatient Setting
NCT01605474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Aims
In conducting this study, the investigators will accomplish the following specific aim:
To compare the length of inpatient care for women undergoing cervical ripening with a transcervical Foley placed in the outpatient vs. inpatient setting prior to induction of labor.
* Primary outcomes of interest
* The length of time (measured in minutes) spent on the inpatient unit (L\&D) from admission for cervical ripening and/or labor induction until delivery.
Outpatient arm:
Time for the participants in the outpatient group will be measured from the time the participant is admitted to the hospital for induction of labor until she delivers.
Inpatient arm:
Time for the participant in the inpatient group will be measured from the time the participant is admitted to the hospital for cervical ripening with balloon placement and induction until she delivers.
Time from admission to L\&D until delivery = total INPATIENT until delivery (hours)
• Cost Analysis
Cost/charges will be calculated for the time spent in the outpatient and inpatient unit for both randomization groups.
Cost will be based on information obtained from Enterprise Analytics charges for the time each participant spends in outpatient care, inpatient care, hospitalized from admission to the L\&D unit to delivery.
The investigators will report on the delta/difference in average costs of outpatient and inpatient care between the outpatient and inpatient arms of the study.
Information will be obtained from the finance department at LVHN.
* Secondary outcomes of interest to be compared by randomization groups include:
* maternal outcomes
* mode of delivery, chorioamnionitis, endometritis, placental abruption, urinary tract infection, preeclampsia, wound infection, venous thromboembolism, maternal treatment with postpartum antibiotics
* neonatal outcomes
* neonatal birthweight, Apgar scores, admission to the neonatal intensive care unit (ICU), neonatal ICU length of stay, neonatal hypoglycemia, neonatal sepsis, neonatal seizures, meconium aspiration, intubation for respiratory support, neonatal length of stay (total), umbilical cord gas pH, neonatal death or stillbirth
* dosing of narcotic medications before regional anesthesia
* total oxytocin infusion dosing
* total length of stay for mothers and neonates
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outpatient cervical ripening
Placement of transcervical Foley balloon for cervical ripening in outpatient setting
Outpatient Foley balloon placement
Cervical ripening with balloon placement in the outpatient setting
Inpatient cervical ripening
Placement of transcervical Foley balloon for cervical ripening in inpatient setting
Inpatient Foley Balloon placement
Cervical ripening with balloon placement in the inpatient setting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Outpatient Foley balloon placement
Cervical ripening with balloon placement in the outpatient setting
Inpatient Foley Balloon placement
Cervical ripening with balloon placement in the inpatient setting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled induction of labor with indication and timing supported by Lehigh Valley Health Network -Labor and Delivery Units (Cedar Crest \& Muhlenberg)
* Singleton gestation
* Cephalic presentation
* Amniotic fluid index normal
* Formal prenatal ultrasound during the pregnancy documenting the absence of placenta previa
* Bishop score \<6 and cervical dilation \<3cm at the time of decision to induce labor
* The woman is able to give appropriate consent and has undergone an informed consent process.
* Maternal age ≥ 18 years old at the time of consent
* English speaking
Exclusion Criteria
* Need for inpatient observation or continuous fetal monitoring during their cervical ripening
* New diagnosis requiring immediate hospitalization for monitoring (such as new onset hypertensive disease of pregnancy)
* Vaginal bleeding
* Active labor
* Premature rupture of membranes
* Uterine tachysystole (\>5 contractions in 10 minutes)
* Non-reassuring fetal heart tracing before Foley placement
* Intrauterine fetal demise diagnosed after enrollment and before placement of balloon
* Contraindication to vaginal delivery, relative or absolute (i.e. transfundal uterine surgery)
* Abnormal placentation including a low lying placenta
* Prior cesarean delivery
* Known fetal major anomaly
* Human immunodeficiency virus, Hepatitis C, or active herpes infection
* Maternal cardiopulmonary disease requiring cardiac monitoring during labor
* Pregestational diabetes or GDMA2
* Rh isoimmunization
* Non-English speaking
* BMI \> 40
* Distance from the hospital over 60 minutes by car, unreliable communication via telephone, or unreliable transportation
18 Years
39 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lehigh Valley Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joanne Quinones, MD
Vice Chair Research, Dept OBGYN, Lehigh Valley Health Network
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00000949
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.